GlassScriptPhysician profile
Mary C Cerni
NPI 1164519989
$3,437.44
in general payments reported to CMS, 2019-2025
22 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $983 · 2020: $486 · 2021: $506 · 2022: $478 · 2023: $483 · 2024: $376 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $984.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $983.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $687.91 | 2019-2024 | Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $414.09 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $333.35 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $320.11 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $306.18 | 2019-2024 | Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $302.76 | 2019-2024 | Jardiance |
| Novo Nordisk INC | $257.61 | 2020-2024 | Rybelsus, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $143.46 | 2022-2024 | Eliquis |
| Nova Eye, INC. | $125.00 | 2025 | |
| Abbott Laboratories | $124.82 | 2022-2024 | Freestyle Libre 3 |
| Abbvie INC. | $96.33 | 2019-2023 | Ubrelvy |
| Allergan, INC. | $52.42 | 2019-2020 | |
| Mylan Specialty L.P. | $43.94 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $35.34 | 2019 | |
| Amarin Pharma, INC. | $34.74 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $28.94 | 2019 | |
| Amag Pharmaceuticals, INC. | $28.52 | 2019 | |
| Exact Sciences Corporation | $22.55 | 2024 | Cologuard Collection Kit |
| Boston Scientific Corporation | $22.30 | 2024 | |
| Astellas Pharma US INC | $22.18 | 2023 | Veozah |
| Biohaven Pharmaceutical Holding Company LTD. | $21.77 | 2022 | |
| Amgen INC. | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Cerni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.